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Abstract
Background: Nigeria accounts for 25% of  cases of  Female genital mutilation (FGM) worldwide, with increased incidence of  
cervical cancer.
Objective: This study was aimed at evaluating the relationship between FGM and HPV in a locality with high prevalence of  
FGM.
Methods: Papanicolaou test, DNA hybridization using Polymerase Chain Reaction (PCR), and flow-through hybridization 
was done to determine the genotypic variants of  the HPV. Physical examination and questionnaires were also used to ascertain 
presence of  FGM.
Results: FGM was found among 98(49%) subjects, while 23(11.5%) had one or more genotype of  HPV. Majority of  the cases 
of  HPV (78.3%) occurred in FGM subjects. Seventeen Genotypes of  HPV were found among subjects with FGM consisting of  
11 high risk (16, 18, 31, 33, 35, 39, 52, 56, 73, 81, 82) and 6 low risk (43, 44, 6, 26, 84, 70). A correlation (p value = 0.0052 at 95% 
CI) was found between FGM and HPV prevalence with a positive result for post hoc analysis. Results show the first reported 
case of  quintuple HPV infection in a single subject in Nigeria.
Conclusion: FGM needs to be halted as it has no known health benefit yet may increase the risk for cervical cancer.
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Introduction
Human papillomavirus virus (HPV) infection is one of  
the most common viral sexually transmitted infections in 
the world.1 Persistent infection by high risk HPV have 
been associated with the development of  cervical cancer2 
and more recently oropharyngeal cancer.3 HPV preva-
lence rate among women with normal cytology rang-
es from 10%-26%.3 The high prevalence rate of  HPV 
among Nigerian women leads to a corresponding risk in 
the increase of  cervical cancer cases in Nigeria. Current-
ly, cervical cancer is the second highest cause of  cancer 
deaths among Nigerian women2, with 8,240 deaths oc-
curring annually in Nigeria accounting for 49.8% and 
3.1% of  cervical cancer related deaths in West Africa and 
globally respectively.3
Also, female genital mutilation (FGM) is still a common 
practice in Nigeria. Nigeria has the highest number of  
women that has undergone female genital mutilation in 
the world, accounting for about 25% of  all cases of  female 
genital mutilations in the world.4 With no health benefit 
attributed to this practice, various health complications 
both short term and long term have been the bane of  
women and children subjected to this ignoble practice.5 
Some of  the short term effects of  FGM include severe 
pain, shock, hemorrhage, urinary tract infection to some 
long term effect such permanent damage to the female 
genital tissue, chronic inflammation, long life trauma and 
permanent damage to the urethra.4,5 Various factors such 
as religion, traditions, beliefs have led to increased prac-
tice of  FGM. However, younger women tend not to sup-
port this harmful practice. It is worthy of  note that FGM 
violates the fundamental human rights of  women.4,5
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Various risk factors have been associated with the prev-
alence of  HPV and cervical cancer including smoking, 
parity,6 alcohol, continuous usage of  steroid contracep-
tives.7 Generally, the risk factors associated with HPV 
prevalence is largely attributed to both biological and be-
havioral factors. However, there are no literature linking 
the prevalence of  HPV to FGM or considering FGM as a 
probable risk factor in HPV prevalence. However, WHO5 
indicated that FGM could result in an increased risk of  
cervical cancer while stating that more research needed 
to be done.
Hence this study was carried out to determine a signifi-
cant association between HPV and FGM prevalence in 
Ilorin, Nigeria.
Materials and method
Sampling
This study was carried out in Ilorin, Kwara state. A con-
secutive sampling of  200 women determined using Fish-
er’s formula for cross sectional study were surveyed for 
this study. The subjects also met the inclusion criteria for 
HPV testing including age, being sexually active, parity 
and subjects who have not had complete or total hyster-
ectomy. Sampling was carried out in Ilorin in November 
2016.
Study population
The study was carried out among consenting women 
within the ages of  15yrs and 60yrs (note: choice of  age 
range starting from 15yrs was necessitated by the com-
mon age of  first child birth in the study area which is of-
ten at 15yrs), who met the inclusion criteria, attending the 
Family planning clinics of  Sobi Specialist Hospital, Ilorin. 
A structured close ended questionnaire was administered 
to these subjects. Informed consent was obtained from 
all individual participants included in the study.
Data collection
Questionnaires were administered to subjects who met 
the inclusion criteria. The response to the questionnaire 
gave information about; Socio-demographic characteris-
tics such as age, sex, and the socioeconomic status such 
as level of  education and occupation. It also gave infor-
mation about patient’s history of  disease, awareness, and 
patient’s disposition with respect to various risk factors 
associated with HPV and cervical cancer.
Sample collection and analysis
Cervical smears were collected using a cytobrush by a 
Gynecologist and immediately placed in a preservative 
liquid and transported to the laboratory. FGM was de-
termined through self-report and clinical examination by 
a gynecologist during pap smear collection. The samples 
were collected and taken to the laboratory for the follow-
ing analysis; Papanicolaou test, DNA hybridization using 
Polymerase Chain Reaction (PCR), and flow through hy-
bridization was done to determine the genotypic variants 
of  the HPV. For Pap test, Lituo (Liquid based cytology) 
was utilized instead of  the conventional cytology to aid 
proper recovery of  HPV DNA present. For Pap smear 
staining, the conventional staining procedure as described 
by Papanicolaou8 was done with cytology slides classified 
according to The Bethesda System for Reporting Cervi-
cal/Vaginal Cytologic Diagnose.
Molecular characterization of  HPV genotypes
HPV testing was performed at Nova Diagnostics Nige-
ria. DNA extraction was done using DNA extraction kits 
(Integrated technologies, USA) according to the manu-
facturer’s instruction. For the molecular characterization 
of  HPV, The GenoFlow (GF) was used. GenoFlow de-
veloped by Diagcor Bioscience Inc., as the capacity of  
genotyping 33 types of  HPV including 17 high risk (gen-
otypes: 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 
66, 68, 73 and 82) and 16 low risk (genotypes 6, 11, 26, 
40, 42, 43, 44, 54, 55, 57, 61, 70, 71, 72, 81 and 84) with a 
universal probe to determine other variants of  HPV not 
captured among the 33. It uses a modified PGMY primer, 
using it for the amplification of  HPV L1 region.
PCR was performed in a thermocycler (Thermocell, Chi-
na), the reaction mixture was utilized as stated by Diagcor. 
The reaction sequence was as follows; initial incubation 
at 95°C for 9 min, and then went through 43 cycles of  
denaturation at 95°C for 20 s, annealing at 55°C for 30 s, 
elongation at 72°C for 30 s. A final extension was carried 
out at 72°C for 5 min. After amplification, hybridization 
was carried using the Genoflow utilizing flowthrough hy-
bridization. This was done after rigorous washing with 
the hybridized DNA detected using streptavidin-alkaline 
phosphatase followed by colorimetric development us-
ing nitroblue tetrazolium–5-bromo-4-chloro-3-indolyl-
phosphate (NBT-BCIP). Relationship between FGM and 
HPV infection was established using Chi-square test with 
a value corresponding to P < 0.05 regarded as significant. 
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Using logistic regression confounding variables were 
equally control in establishing the relationship between 
FGM and HPV.
Results
The demographic activities of  the study population are 
represented in Table 1. Majority of  the women under 
study were Muslims, had some form of  formal education 
and married. Results from this study shows that only 2 
(1.0%) of  the subjects showed one or more form of  cer-
vical cytology abnormality. The abnormalities seen among 
the subjects were Low grade Squamous Intraepithelial 
Lesions (LSIL). Results also showed that 23 (11.5%) sub-
jects had one or more genotype of  HPV.
Table 1: Demographic characters of the study population 
 
Demographic Characteristics Study 
Population 
(%) 
Age of subjects 15-20years 12 (6) 
  21-30years 128 (64) 
  31-40years 56 (28) 
  41-50years 4 (2) 
  Total 200 (100) 
      
Type of Education Formal Education 180 (90) 
  Informal Education 20 (10) 
  Total 200 (100) 
      
Highest level of 
Education 
Primary Education 12 (6) 
  Secondary Education 60 (30) 
  Tertiary Education 108 (54) 
  Informal Education 20 (8) 
  Total 200 (100) 
      
Religion Christian 12 (6) 
  Muslims 184 (92) 
  Others 4 (2) 
  Total 200 (100) 
      
Marital status Married 196 (98) 
  Single 4 (2) 
  Widow 0 (0) 
  Total 200 (100) 
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Furthermore, FGM was found among 98 (49%) subjects 
with majority of  the cases of  HPV infection (78.3%) 
found among subjects with FGM (Table 2). Similarly, the 
two incidence of  LSIL were found to be present among 
subjects with FGM and the smears contained multiple 
genotypes of  HPV. A total of  17 different genotypes of  
HPV were found in this study consisting of  11 high risk 
(16, 18, 31, 33, 35, 39, 52, 56, 73, 81, 82) and 6 low risk 
(43, 44, 6, 26, 84, 70) genotypes.. Furthermore, the results 
from Table 2 show that the prevalence of  any HPV was 
higher among women with FGM compared to women 
without FGM [18 (78.3%) vs. 5 (21.7%), crude Odds Ra-
tio=4.37, 95% Confidence Interval: 1.5520 to 12.2769] 
as was the prevalence of  any HR-HPV [19 (95%) vs. 1 
(5%), crude Odds Ratio= 12.67, 95% Confidence Inter-
val: 1.1772 to 13.6]. 
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Table 2: Relationship between female genital mutilation and HPV infection 
  Risk factors Subjects with female 
genital mutilation 
X2(p value) 95 % CI Odds ratio  
    Yes No       
HPV 
Prevalence 
Positive 18 5 7.63 (0.01) 1.56 to 12.28 4.37 
Negative 80 97       
              
              
HPV 
Genotypes 
High Risk 19 1 5.88 (0.15) 1.18 to 13.60 12.67 
Low Risk 6 4       
              
Co-infection Multiple HPV infections 9 2 0.01 (0.67) 0.13 to 9.61 1.11 
Single HPV infection 10 2       
              
 P value <0.005 is statistically significant 
Table 3 shows the risk factors that showed positive cor-
relation to HPV prevalence. The relationship between 
HPV, FGM and these risk factors which are potential 
confounding variables. Risk factors with the least expos-
ue to HPV infection were chosen as the reference groups 
(Table 3). Table 4 shows the relationship between FGM, 
HPV infection and confounding variables.
Table 3: Risk factors associated with HPV infection 
  
  HPV Infection     
Yes No X2 (P value) OR (95% CI) 
Age of subjects 15-20years 2 8 8.3 (0.04) 0.08 (0.03-0.13) 
21-30years 15 73     
31-40years 6 62     
41-50years 0 34     
            
Sex at an Early Age Yes 17 80 6.72 (0.01) 0.29 (0.11-0.77) 
No 6 97     
            
Sexual Partner Circumcised? Yes 15 70 5.49(0.02) 0.3489 (0.14-0.87) 
No 8 107     
            
Subjects in a polygamous 
marriage? 
Yes 16 62 10.21 (0.00) 0.2359 (0.09-0.60) 
No 7 115     
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 Table 4: Regression analysis of the relationship between HPV Infection and FGM  
 
 Coefficientsa 
Model Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. 95.0% Confidence Interval 
for B 
B Std. 
Error 
Beta Lower 
Bound 
Upper Bound 
1 (Constant) 1.682 0.071   23.849 0.000 1.543 1.821 
Subjects with FGM 0.135 0.044 0.211 3.037 0.003 0.047 0.222 
2 (Constant) 1.480 0.098   15.131 0.000 1.287 1.673 
Subjects with FGM 0.134 0.044 0.209 3.068 0.002 0.048 0.219 
Age of subjects 0.077 0.027 0.199 2.911 0.004 0.025 0.129 
3 (Constant) 1.506 0.097   15.520 0.000 1.314 1.697 
Subjects with FGM 0.904 0.305 1.417 2.960 0.003 0.302 1.506 
Age of subjects 0.074 0.026 0.189 2.809 0.005 0.022 0.125 
Sex at an Early Age -
0.778 
0.305 -1.220 -2.548 0.012 -1.381 -0.176 
4 (Constant) 1.377 0.107   12.843 0.000 1.166 1.589 
Subjects with FGM 0.922 0.301 1.444 3.063 0.003 0.328 1.515 
Age of subjects 0.078 0.026 0.201 3.028 0.003 0.027 0.129 
Sex at an Early Age -
0.860 
0.303 -1.347 -2.842 0.005 -1.456 -0.263 
Been Wife in a 
polygamous 
marriage 
 
0.132 0.050 0.202 2.634 0.009 0.033 0.231 
a. Dependent Variable: HPV Infection 
 
Analysis showed a minimal effect in the odds ratio of subjects with FGM in the second model when the predictor age was added. Thus age alone 
was not a confounding variable. However, in the models 3 and 4 when two additional predictors were added, there was a corresponding positive 
increase in the odds ratio of the predictors. 
Discussion
This study provides a comprehensive reports on the 
genotypic variants of  HPV present in a North Central 
state of  Nigeria with High level prevalence rate of  FGM. 
Majority of  the subjects were found between the age of  
21-30 years accounting for 128 (64.0%) of  the study pop-
ulation. This was not surprising, as sampling was done 
among women attending family planning clinics of  the 
surveyed hospital. Majority of  the women belonged to 
the child bearing age which forms the fulcrum of  this 
study. Mbamara et al.9 Odusolu et al.10 and Schluterman et 
al.11, also recorded this age range as been the most prev-
alent in their study of  HPV infection among a cohort 
of  women. They had a prevalence rate of  52%, 66.6%, 
80.6% respectively.
Results revealed that out of  the 200 women who par-
ticipated in the study, 198 (99.0%) had normal cytology 
(they were negative for intraepithelial lesion or malignan-
cy), while 2 (1.0%) women had abnormal cytology (they 
were positive for intraepithelial lesion or malignancy). 
The prevalence of  1.0% abnormal cytology in this study 
is different from that reported by Durowade et al.13 in 
Kwara state, which reported a prevalence rate of  5% for 
abnormal cytology. Although the result of  99.0% for nor-
mal cytology is higher than those reported by Adekunle 
and Samaila13 who reported 74.5% normal cytology, and 
Odusolu et al.10 who reported the prevalence of  normal 
cytology as 83.7% it is worthy of  note that majority of  
these studies were retrospective, and a large section of  
such patients were not voluntary, but patients who already 
had gynecological problems and cytology was recom-
mended. This is likely going to result in higher number of  
abnormal cytology compared to this study which utilized 
normal women with no related gynecological problems. 
Thomas .4 reported a prevalence of  9.4% abnormality 
for a similar study in Ibadan.
A key feature of  this study is establishing the relationship 
between FGM and HPV prevalence. Although no direct 
relationship has been drawn between HPV prevalence and 
FGM in the past, a significant difference existed statical-
ly (p value =0.0052, 95% CI 1.5520 to 12.2769). Results 
from the linear regression analysis carried out on Table 
4 further establishes this relationship between HPV and 
FGM. After standardizing for age of  the subjects, there 
was minimal effect on the odds ratio (0.135 to 0.134) of  
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the subjects with FGM. However, there was a significant 
positive change of  the odds ratio to 0.904 and 0.922 after 
adjusting for subjects who had sex at an early age and 
subjects in a polygamous marriage.  The high prevalence 
of  FGM (49%) among the subjects shows that FGM is 
still a common practice in Ilorin, Nigeria. It is worthy of  
note that this study did not seek out directly subjects with 
FGM, rather subjects attending family planning clinics 
were recruited.
It has been noted that FGM has no known health bene-
fits (WHO, 2016) yet the health risk associated with it are 
numerous. It was clearly noted in this study that High risk 
HPV was found more commonly in subjects in subjects 
with FGM. The reason for this is not yet established as 
there is a dearth of  literature focusing on the infection 
acquisition mechanism of  women with FGM, as most 
studies focuses on epidemiological studies of  FGM.16 
The presence of  abnormal cytology and higher presence 
of  multiple HPV infections among these women with 
FGM further shows that FGM could be a potential risk 
factor in the prevalence of  HPV infection and thus cer-
vical cancer.
Results from this study showed that 11.5% of  the study 
population had one or more HPV infection. This is rel-
atively high as majority of  these women with HPV in-
fection had normal cytology i.e. were negative for in-
traepithelial lesions. While Al-Awadhi et al.17 reported a 
prevalence of  2.4% among women with normal cervical 
cytology in Kuwait, Adenis et al.18 reported a prevalence 
rate of  27.2% among women with normal cytology in 
French Guiana. Although Adenis et al.18 reiterated that 
the figure stated in their research was among the highest 
in the world.
A total of  17 different genotypes of  HPV were found in 
this study consisting of  11 high risk (16, 18, 31, 33, 35, 
39, 52, 56, 73, 81, 82) and 7 low risk (43, 44, 6, 26, 84, 70) 
genotypes. The use of  flow through hybridization as uti-
lized in this study has been shown to possess the ability to 
identify 33 different genotypes of  HPV.19  While Nyengi-
diki et al20 and Kolawole et al.21 obtained 4 genotypes 
of  HPV (16, 18, 31, 35) in studies in Port Harcourt and 
Lokoja Nigeria respectively.
Furthermore, subjects with abnormal cytology i.e. Low 
grade Squamous Intraepithelial Lesions (LSIL) found in 
this study had multiple HPV genotype. This study also re-
ports the presence of  quintuple infection of  HPV (HPV 
70, 33, 73, 81, 82). This was found among subjects with 
Low grade squamous intraepithelial lesions. This is the 
first report on quintuple HPV infection in a single subject 
in Nigeria. Sharifah et al.22 obtained high risk HPV ge-
notypic variants of  16, 18, 31, 51, 52, 56, 58 and 66, from 
abnormal cervical smears, with the highest frequency of  
genotypes occurring in LSIL smears. Thomas et al.14 ob-
tained similar results in Ibadan, Nigeria where the com-
mon high risk HPV genotypic variants found among the 
subjects were 16, 31, 35 and 58.  These cases of  multiple 
infections tend to have been more common in subjects 
FGM. Other factors such as age of  the subjects, being 
in a polygamous marriage and sexual partner circumci-
sion all had a statistical relationship with HPV prevalence. 
These factors have been previously established as poten-
tial risk factors for HPV infection and cervical cancer.2 
Thus focus was not placed on their individual ability to 
increase HPV prevalence, but as confounding variables 
as shown in Table 4.
While the relationship between cervical cancer, FGM and 
HPV infection is still not well understood. Some stud-
ies have also drawn a relationship between FGM and in-
vasive cervical cancer. Osterman23 reported that in their 
analysis of  Senegalese women with and without cervical 
abnormalities and invasive cancer, a strong association 
between FGM and invasive cervical cancer was found. 
It is not exactly clear while subjects with FGM are more 
likely to develop cervical cancer but a look at the onco-
genic mechanisms of  most cancerous cells has shown a 
direct correlation between inflammation which is a pri-
mary defense mechanism by the body against infections 
and carcinogenesis.24 Sexually transmitted infections such 
as HPV, herpes simplex type are known to also induce 
inflammatory response.25 With chronic inflammation one 
of  the prolonged effect of  FGM, it thus can be argued 
that women with FGM especially those with chronic in-
flammatory responses are more likely to develop cervi-
cal cancer. Furthermore, studies have shown that FGM 
increases the risk of  having bacterial vaginosis (BV).26 
Morrison et al26 in their study of  the long term effect 
of  FGM among a rural community in Gambia noted that 
women with FGM had a higher prevalence of  BV at an 
adjusted odds ratio (OR)=1.66; 95% confidence interval 
(CI) 1.25–2.18. This is important because different stud-
ies have shown that the presence of  BV among subjects 
significantly increases their risk of  acquiring HPV in-
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fection. While the actual mechanism is not known, this 
strong correlation cannot be overlooked.27,28,29 Thus one 
can imply that FGM which significantly increases the risk 
of  genital inflammation as well as BV, invariably increas-
es the risk of  acquiring HPV infection and thus cervical 
cancer. Also, a link has been established between HPV 
infection and BV in women. Studies have shown that BV 
which is characterized by low level of  Lactobacillus spp, 
increased prevalence of  anaerobes,30 is linked with per-
sistent HPV infection and developing precancerous le-
sions.31,32 Although it was observed in this study that the 
two subjects already developing cervical neoplasia had 
high risk HPV, the data is too small to make any conclu-
sion from that.
This study clearly establishes a statistical correlation be-
tween HPV and FGM prevalence. However, there is a 
need to take a further look at the role other risk factors 
associated with HPV infection play vis-à-vis FGM among 
a cohort of  women with only FGM. Meanwhile there is 
a need to increase the awareness of  Nigerians about the 
dangers of  FGM in other to curb this abuse that is still be 
perpetuated against women in Nigeria.
Limitation of  study
The type of  FGM the subjects had were not considered. 
This could be relevant in understanding cervical cancer 
pathogenesis.
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